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tures  and unique  chemical  and  physical  properties.  Their application  in various  ﬁelds  is well  covered  in  the
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summarizes  the  impact  of  the  vast  class  of  POMs  on  the  formation  of  protein  crystals,  a  well-known  (frus-
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particular  emphasis  focused  on  POM’s  potential  as  a powerful  crystallization  additive  for  future  research.
The  Protein  Data  Bank  (PDB)  was scanned  for protein  structures  with incorporated  POMs  which  were
assigned  a PDB  ligand  ID  resulting  in  30 PDB  entries.  These  structures  have  been  analyzed  with regard  to (i)
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the  structure  of POM  itself  in  the  immediate  protein  environment,  (ii)  the  kind of  interaction  and  position
of the  POM  within  the protein  structure  and  (iii)  the beneﬁcial  effects  of  POM on  protein  crystallography
apparent  so  far.
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. Introduction
.1. The bottleneck in macromolecular X-ray crystallography
To understand the function of proteins and potentially inves-
igate the pharmacological interactions of new drugs at the
olecular level, it is essential to determine the three-dimensional
tructure of biomolecules. X-ray crystallography is currently the
ethod of choice that is widely utilized in the ﬁeld of struc-
ural biology in order to provide important structural information.
ost of the structures deposited in the Protein Data Bank (PDB;
ww.pdb.org) were determined via this method (about 89% as
f November 2014) due to its ability to provide atomic resolu-
ion structures of a wide range of proteins. There are however a
umber of obstacles in macromolecular X-ray crystallography to
vercome. The biggest two hurdles are (1) obtaining good single
rystals diffracting to high resolution in the X-ray diffraction exper-
ment and (2) the so called “phase problem”. The latter occurs
ecause detectors used in X-ray diffraction experiments are only
ble to measure the intensity of the diffracted light, but not its
hase information which carries the bulk of the structural informa-
ion. The state of the art approach to tackle this problem is either
sing the phases of a structurally related protein as a starting point
or reﬁnement (molecular replacement, MR)  or for new protein
lasses where no homologous protein is available, the introduction
f heavy atoms and/or anomalous scatterers via either soaking or
o-crystallization. Initial phases can then be obtained by single or
ultiple isomorphous replacement (SIR, MIR), single- or multiple-
avelength anomalous dispersion (SAD, MAD) or a combination of
oth techniques such as single or multiple isomorphous replace-
ent with anomalous scattering (SIRAS, MIRAS) [1–3]. Due to the
ast technological progress of synchrotron facilities and particularly
he development of software suites for the automated structure
etermination in the past decades, the phase problem is becoming
ore and more of a minor obstacle. Thus, obtaining high quality
ingle crystals remains the real bottleneck in macromolecular crys-
allography to date [4]. Protein crystallization is still mainly a “trial
nd error” procedure which depends on various factors e.g. pro-
ein and precipitant concentration, pH, buffer, temperature, ionic
trength, the presence of impurities and other unknown factors [5].
herefore, protein crystallization can be very time consuming with
o guarantee of success, which is especially true for membrane
roteins [6]. This group of proteins is poorly soluble in aqueous
onditions because of their membrane interacting hydrophobic
ortions and thus presents a tough challenge in protein crystal-
ization.
In many crystallization trials varying the aforementioned con-
entional parameters fails to obtain high quality crystals, but
ertain compounds and/or small molecules, referred to as additives,
xhibit signiﬁcant effects on the successful crystallization of indi-
idual proteins. Most of these additives are bound by the protein
often for physiological reasons) and induce physical and chemical
hanges, or conformational changes which are favorable for pro-
ein crystallization. The additive-bound form is often structurally
ore stable than the apo-form due to intermolecular, non-covalent
rosslinks in proteins, which promote crystal lattice formation
7,8]. Common additives are e.g. divalent metal ions, which often
acilitate correct folding for some proteins, or substrates/inhibitors
tabilizing certain conformations of enzymes. However, ﬁndinghed  by Elsevier  B.V.  This  is  an  open  access  article under  the  CC  BY  license
(http://creativecommons.org/licenses/by/4.0/).
the appropriate additive that does exhibit the desired effect on
crystallization is an empirical process and thus a similarly time con-
suming process of “trial and error”, like the crystallization process
itself.
In the search for a powerful group or class of additives that
is able to promote crystallization of at least a certain group of
proteins the class of polyoxometalates (POMs) was found as a
promising candidate. POMs attracted attention in the ﬁeld of pro-
tein crystallography when they were used during early stages of the
crystallization and structure elucidation process of the ribosome
which was later awarded with the Nobel prize for chemistry in 2009
[9]. In the Yonath group the treatment of crystals of the small ribo-
somal subunit with the Wells–Dawson type POM K6[P2W18O62]
enhanced the crystalline arrangement and resulted in improved
diffraction power [10,11]. Although POMs have been mainly used
for phasing reasons and not for obtaining crystals the crystalliza-
tion of the small ribosomal subunit showed that K6[P2W18O62] and
thus maybe other POMs could have great potential as crystallization
additives due to their predominantly electrostatic interaction with
macromolecules. The binding of negatively charged POM molecules
to positively charged protein surface patches is able to rigidify por-
tions of the macromolecule which are otherwise very ﬂexible and
thus hinder crystal formation [10,12]. The reduction in ﬂexibility
leading to crystal stabilization is an indispensable prerequisite for
protein crystallization, thus making POMs a great candidate for the
use as crystallization additives.
Recently, we were the ﬁrst to present the structures of both
the latent and active forms of mushroom tyrosinase PPO4 from
Agaricus bisporus crystallized as a heterodimer in one single crys-
tal [13,14]. The crystals were only obtained in the presence of
Na6[TeW6O24]·22H2O (PDB ligand ID: TEW, associated PDB entry:
4OUA). The POM bound to positively charged surface regions of two
monomers leads to the reduction of repulsive forces between them
and does thus provide new crystal contacts which in turn promote
lattice formation. In order to conﬁrm the charge interplay between
proteins and POMs as the key element in crystal formation, we  crys-
tallized the model protein hen egg white lysozyme (HEWL, pI ∼ 11)
with Na6[TeW6O24]·22H2O (PDB entry: 4PHI). HEWL was chosen
for use since it crystallizes under a wide range of conditions and
especially due to its highly positive charge making it ideal for inter-
action with negatively charged POMs. The structure revealed that
the POM molecules participated in crystal lattice formation lead-
ing to a new crystal form [15]. As a result, we more recently solved
the crystal structure of latent aurone synthase from Coreopsis gran-
diﬂora obtaining the best diffracting crystals by co-crystallization
with Na6[TeW6O24]·22H2O [16].
Our experiences with Na6[TeW6O24]·22H2O inspired our inter-
est for POM usage in protein crystallization, a mostly unexplored
ﬁeld for the application of POMs. There are only a few articles
reporting on the targeted use of POMs in protein crystallization.
Here we  focus on POMs which were fully or at least partially
modeled in the protein structure and assigned a PDB ligand ID. All
POM–protein interactions, the role of POMs and their impact on the
crystallization and that of the protein structure itself are reviewed.
The relevance of POMs to protein crystallization will be discussed
with an outlook regarding its use as a crystallization tool, as we
believe that the usage of appropriate POMs should be exploited to
a greater extend in protein crystallization and subsequent structure
analysis.
24 A. Bijelic, A. Rompel / Coordination Chemistry Reviews 299 (2015) 22–38
Fig. 1. Polyhedra structure of the most prominent POM archetypes. In every
structure the POM-forming addenda metals (M)  are shown as cyan polyhedra, het-
eroatoms (X) either as brown polyhedra or brown sphere and oxygen atoms as small
red spheres on the edges of the addenda metal polyhedra. (A) Keggin archetype. (B)
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Fig. 2. Graphic showing the most frequent POM–protein interactions. A proteoly-
tic active POM [Ce(-PW11O39)2]10− consisting of a strong Lewis acid metal ion,
Ce(IV), connected to a Keggin structure is used as illustrative model. The Keggin
structure is shown in polyhedral presentation with addenda atoms as gray polyhe-
dra,  heteroatom as yellow polyhedron, POM oxygens as small red spheres and theells–Dawson archetype. (C) Anderson–Evans archetype. (D) Lindqvist archetype.
E) Preyssler archetype viewed along the ﬁvefold axis.
.2. Polyoxometalates
Polyoxometalates (POMs) are anionic metal oxide clusters of
arly transition metals in their highest oxidation state, mainly
olybdenum(VI), tungsten(VI) and vanadium(V). This vast class
f compounds exhibits interesting features in terms of molecu-
ar composition, size, solubility, shape, charge density and redox
otential. POMs are useful for applications in a variety of domains
17], including catalysis [18,19], photochemistry [20,21], material
cience [22] and medicine [23]. POMs are divided into isopoly-
nd heteropolyoxoanions of the general formula [MmOy]n− and
XxMmOy]n−, respectively, where M is referred to as the addenda
tom and X as a heteroatom [24]. POM structures are formed
ia the assembly of {MOn} polyhedra that are most commonly
ctahedral, connected to each other via one (corner sharing), two
edge sharing) or rarely three oxygen atoms (face sharing). POMs
re in general obtained by the condensation (self-assembly pro-
ess) of the addenda metal anions (MoO42−, VO43− or WO42−)
pon acidiﬁcation leading to isopolyoxometalates or in the pres-
nce of heteroatoms containing oxo/hydroxoanions [XOy(OH)x]n−
o heteropolyoxometalates [25,26]. The nature of the resulting
OM depends on the stoichiometry, the solvent used, pH, tem-
erature, concentration of the POM-forming metal and counter
ations, etc. The most common POM structures are the Keggin [27],
ells–Dawson [28], Anderson [29], Lindqvist [30] and Preyssler
31,32] archetypes (Fig. 1). Keggin was the ﬁrst determined POM
tructure with the general formula [XM12O40]n−, where the cen-
ral tetrahedron (XO4) is caged by 12 MO6 units connected to
ach other by adjacent oxygen atoms. The 12 metal centers in the
ctahedra form a sphere around the tetrahedron core which can be
ubdivided into four {M3O13} units leading to an overall tetrahe-
ral symmetry for the structure (Fig. 1A). Each MO6 octahedron is
haring two edges with other MO6 units, within the triad of MO6
ctahedra forming one-fourth of the addenda skeleton. Thus, four
M3O13} groups are attached to one another via corner sharing
esulting in the complete Keggin structure. There are ﬁve Keggin
somers (marked by the preﬁxes , , ,  and  in the formula)
iffering only in the orientations of the {M3O13} building blocks.
he Wells–Dawson structure [X2M18O62]n− is closely related to
he Keggin structure, because its formation is based on the fusion
f two truncated [XM9O34]n− Keggin fragments by sharing of sixhydrolytically active Ce(IV) metal ion as an orange sphere. Protein main and side
chains are shown as sticks (color code: carbon atoms = green, nitrogen atoms = blue,
oxygen atoms = red).
oxygen atoms resulting in the M18-compound (Fig. 1B) [33,34]. The
Anderson structure [XM6O24]n− has an octahedral central atom,
which is surrounded by a ring of six coplanar MO6 octahedra shar-
ing edges (Fig. 1C). The Lindqvist structure with a general formula of
[M6O19]n− (isopolyoxometalate) consists of an octahedral arrange-
ment of six MO6 octahedra, wherein each octahedron is sharing four
edges with adjacent octahedra exhibiting full octahedral symmetry
(Fig. 1D). The Preyssler polyoxoanion [Xn+P5W30O110](15−n)− con-
sists of ﬁve PW6 units (one PW6 unit being composed of two groups
of three corner sharing WO6 octahedra) forming a crown giving the
structure an ellipsoid shape with an internal ﬁvefold symmetry axis
(Fig. 1E).
2. POM–protein interactions
POMs possess important biological and pharmacological
attributes like antiviral, antibacterial and anticancer properties
which are most probably based on their interactions with diverse
biomacromolecules [35–40]. Several reports investigating the
interaction between different POMs and proteins exist [41–46]. In
protein crystallization the interaction between the macromolecule
and the additive is very often the basis for successful crystal for-
mation. Thus, the most frequent interactions between POMs and
biomacromolecules are discussed in the following (see also Fig. 2).
2.1. Electrostatic interactions/charge–charge interactions
In studies investigating POM–protein interaction, human serum
albumin (HSA) was often used as it is the most abundant plasma
protein and believed to be the major transporter for various drug
compounds to their target organs [47]. Furthermore, HSA contains
only one single tryptophan in position 214 and therefore its inter-
action with POM can be determined by tryptophan ﬂuorescence
quenching in the presence of diverse POMs via both steady-state
and time-resolved ﬂuorescence measurements [41,42,48]. In all
studies POM–protein interaction has been conﬁrmed based on
clearly increasing quenching constants in the presence of POM. The
negative nature of the POM led to the assumption that the interac-
tion had to be electrostatic and therefore accessible cavities of HSA
with a positive inner surface potential were suggested as POM bind-
ing sites. To conﬁrm electrostatic interaction as the main driving
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Fig. 3. Solvent-mediated interactions in Azotobacter vinelandii (PDB entry: 4F6T). (A) Glutamine (Gln) residue interacts directly with a terminal oxygen of an octamolybdate
via  its N2 nitrogen atom, whereas the interaction between its O2 oxygen atom and the octamolybdate is mediated via the solvent (only the oxygen atom of the water is
shown  as a red sphere). A serine residue is also connected to the same octamolybdate via a solvent molecule. In addition to solvent-mediated POM–protein interactions,
the  ﬁgure also shows a solvent-mediated POM–POM interactions between two neighboring octamolybdates. The hydrogen bond distances between the solvent molecules
and  the binding partners vary from 2.5 to 3.0 A˚ (only the distance between the glutamine carbonyl group and the water is greater with 3.8 A˚). (B) The interaction between
two  protein backbone carbonyl groups and the terminal oxygen atoms of an octamolybdate is mediated by a Mg2+ ion. The distances between the Mg2+ ion and the binding
partners are about 2.4–2.5 A˚. The inset in the same ﬁgure shows the theoretical possible interaction of a negatively charged octamolybdate with a negatively charged side
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chain  (aspartic acid) mediated by a Mg2+ ion. The protein is depicted as a cartoon 
arbon atoms = green/dark green, nitrogen atom = blue and oxygen atoms = red, sulf
llustrated in ball and stick (color code: molybdenum atoms = deep teal, oxygen ato
orce of POM–HSA binding, further experiments were performed
sing differentially charged POMs and applying acidic pH values.
t was found that the higher the negative charge of the POM, the
tronger the binding to the protein [48].
Zhang et al. [43,44] investigated the binding of the Keggin ion
H2W12O40]6− and the Preyssler ion [NaP5W30O110]14− to HSA via
sothermal titration calorimetry indicating that the binding process
s an exothermic process exhibiting negative reaction enthalpies
ith H = −75 kJ/mol for [H2W12O40]6− and H  = −100 kJ/mol
or [NaP5W30O110]14−, respectively (at pH 3.5) [43]. Therefore,
he authors concluded that POM–protein interactions are mainly
f electrostatic nature. The same experiment was  then per-
ormed with differentially charged 2-Wells–Dawson structures
onﬁrming the previous results, with the exception that the only
acunary POM (2-[P2W17O61]10−) used in this study exhibited a
ositive enthalpy (H = +22.7 kJ/mol), although bearing the high-
st charge [44]. The positive reaction enthalpy indicates that the
riving force of the lacunary POM’s interaction with HSA is entropy
nstead of the exothermic electrostatic component.
.2. Hydrogen bonds
POMs can interact with proton donors by hydrogen bonding
42,49]. Altogether, nine amino acids have hydrogen donor atoms
n their side chains, where three of them (arginine, histidine and
ysine) are positively charged at physiological pH due to the high
soelectric points (pIs) of their side chains. Hydrogen bonding is also
 form of electrostatic interaction and might therefore be general-
zed as electrostatic in many studies without distinguishing from
ther charge-mediated interactions. Thus, hydrogen bonds can also
ontribute to the binding of POMs.
Furthermore, X-ray structure analysis of POM–protein com-
lexes revealed that POMs can be “indirectly” hydrogen bonded to
he protein. In the molybdenum/tungsten storage protein (MoSto)
rom Azotobacter vinelandii networks of hydrogen bonds around
ifferent POM molecules were found, where the POM–protein
nteractions are partially mediated by solvent molecules (Fig. 3A)
50,51]. These solvent-mediated interactions have the additional
dvantage that negatively charged POMs can be linked to nega-
ively charged protein side chains via hydrogen bonds (with e.g.
ater as solvent and hydrogen donor) or via electrostatic interac-
ions (with e.g. Mg2+ in the solvent, providing a bridging positive
harge) and thus increasing the binding variety for POMs (Fig. 3B).0% transparency) with interacting side chains shown as ball and stick (color code:
m = yellow) and the magnesium ion as light green sphere. The octamolybdates are
ed).
2.3. Covalent bonds
The molybdenum storage protein was also reported to cova-
lently bind an octamolybdate and a tungsten cluster [50,51]. The
MoSto protein is a ()3 hetero-hexamer consisting of three 
hetero-dimers that form a cavity which looks similar to a pouch.
MoSto is capable of storing 70–100 molybdenum or tungsten
atoms by clustering them which leads to the formation of various
POMs. In all reported X-ray structures of MoSto where the pro-
tein was  pretreated with molybdenum (PDB entries: 4F6T, 4NDO,
4DNP, 4NDQ, 4NDR) some octamolybdates were covalently bound
to the N2 nitrogen of histidine (His156) and the O1 oxygen of
glutamic acid (Glu129) and were therefore assigned the formula
[Mo8O26O(Glu)N(His)Hn]n−5 with O(Glu) and N(His) indicating
that the oxygen and nitrogen atoms, respectively, were provided
by the amino acid side chains (Fig. 4A) [51,52]. Another MoSto
structure (PDB entry: 2OGX), where the protein was expressed
in tungstate containing media without any molybdenum, shows
a covalently bound tungsten cluster [W3O10HxN3](6−x)−. The POM
is located on a crystallographic threefold axis and thus the N3 in the
formula represents three histidine N2 nitrogen atoms which are
stemming from three symmetry related monomers (Fig. 4B) [50].
A second example for a covalent POM–protein interaction is
the structure of Nucleoside triphosphate diphosphohydrolase 1
(NTPDase1) from Legionella pneumophila (PDB entry: 4BVP) where
molybdenum atoms of an octamolybdate [Mo8O28]8− are cova-
lently bound to the hydroxyl oxygen of a serine and the nitrogen
from a His6-tag histidine (Fig. 4C) [53]. These covalent bonds, espe-
cially those with the very ﬂexible C-terminal His6-tag, most likely
rigidiﬁed the protein and thus facilitated the crystallization process.
These examples of the MoSto protein and NTPDase1 demon-
strate that covalent bonds between POMs and proteins are possible,
but so far were only observed under conditions where POM assem-
bly took place in the presence of the protein itself. To date, no
covalent POM–protein bond was found in studies with the POM
administered as an intact cluster.
2.4. van der Waals interactions
van der Waals interactions are very common interactions which
could be part of protein–POM interactions. Poppe et al. described
three molybdenum clusters which are bound to the MoSto pro-
tein via predominantly van der Waals interactions [52]. The
Mo6/Mo7 and Mo13 clusters (composed of 6, 7 and 13 MoOx units,
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Fig. 4. Three examples for covalently bound POMs in the PDB (A: 4F6T, B: 2OGX, C:
4BVP). (A) Covalently bound [Mo8O26O(Glu)N(His)Hn]n−5: one molybdenum atom is
covalently bound to a N2 histidine nitrogen atom, whereas the other molybdenum
is  bound to the O2 oxygen atom of a glutamic acid. Protein scaffold is illustrated
as green cartoon (with 30% transparency), whereas the binding amino acids are
represented as sticks (color code: carbon atoms = green, nitrogen atoms = blue and
oxygen atoms = red). The POM is depicted in ball and stick representation (color
code: molybdenum atoms = deep teal, oxygen atoms = red). (B) Covalently bound
[W3O10HxN3](6−x)− lying on a crystallographic threefold axis. Each tungsten atom
is  covalently bound to the N2 histidine nitrogen atom of three symmetry related
monomers (indicated by different coloring: green, yellow and red, respectively). Pro-
tein  scaffold is illustrated as cartoon (with 30% transparency), whereas the binding
histidines are represented as sticks (color code: carbon atoms = green/yellow/red,
nitrogen atoms = blue). The POM is depicted in ball and stick representation (color
code: tungsten atoms = marine, oxygen = red). (C) Covalently bound [Mo8O28]8−: one
molybdenum atom is covalently bound to the N2 histidine nitrogen of a His6-tag
and  another molybdenum atom to the hydroxyl group of a serine. Both side chains
are originating from different protein monomers (indicated by different coloring:
green and cyan, respectively). Protein scaffold is illustrated as cartoon (with 30%
transparency), whereas the binding side chains are represented as sticks (color code:
carbon atoms = green/cyan, nitrogen atoms = blue, oxygen atoms = red). The POM is
depicted in ball and stick representation (color code: molybdenum atoms = deep
teal, oxygen atom = red).
Fig. 5. Mo13 POM located in a nonpolar hydrophobic region (PDB entry: 4NDO). The
Mo13 POM was not modeled but the 13 molybdenum atoms are illustrated as deep
teal spheres. The protein is represented as differently colored cartoons to indicate
different monomers, whereas the nonpolar side chains of valine, proline and the
polar serine are depicted as sticks (color code: carbon atoms = green/cyan/magenta,
nitrogen atoms = blue, oxygen atoms = red). These side chains are additionally shown
at  the bottom of the ﬁgure to provide a close view. Serine is always depicted with its
alternative conformation (with the second position of the hydroxyl group) where
the hydroxyl positions are designated by the number 1 and 2. The closest amino
acids surrounding the Mo13 POM are all nonpolar (glycines are also present but not
illustrated as sticks). Further away from the cluster there are a few serines in the
predominantly hydrophobic protein portion.
respectively) are located inside the protein-formed pouch and are
attached to nonpolar hydrophobic regions consisting of several
valines, prolines, glycines and a few serines. Therefore it was sug-
gested that both clusters are mainly bound by nonionic, nonpolar
van der Waals interactions (Fig. 5).
2.5. Hydrolytic activity of POMs – an interaction to be avoided in
protein crystallography
Several POMs have been shown to cleave proteins regioselec-
tively and they therefore represent interesting artiﬁcial proteases
since proteolytic enzymes often exhibit substrate promiscuity or
lack sequence speciﬁcity at all. One of them is the Keggin-type
[Ce(-PW11O39)2]10− POM which was  demonstrated to cleave hen
egg white lysozyme selectively at two  positions under physio-
logical conditions (pH 7.4, 37 ◦C) [54]. The negatively charged
POM scaffold interacts electrostatically with a positively charged
protein region and brings its embedded strong Lewis acid metal
(Cerium(IV) ion) in proximity to the target amide bond. The Ce(IV)
atom is then able to interact with the carbonyl group of the amide
bond leading to its polarization and subsequent hydrolysis. Thus,
the POM scaffold function is regioselectivity, whereas the strong
Lewis acid performs the hydrolysis itself. The rate of hydrolysis
(10−3 h−1) of [Ce(-PW11O39)2]10− is approximately 40–400 times
less than for Ce(IV)-salts like Ce(NH4)2(NO3)6·4H2O (4 × 10−2 to
4 × 10−1 h−1) [54] most probably due to the decrease in Lewis acid-
ity as a result of Ce(IV) complexation. However, the remarkable
POM mediated regioselectivity excels that exhibited by many pro-
teases.
A second study by the same group demonstrated the ability
of different zirconium containing POM-based complexes to selec-
tively hydrolyze human serum albumin at pH 7.4 and 60 ◦C [55].
The complexes differed in their number of zirconium-ions (contain-
ing one, two  or four Zr(IV) ions) and the POM archetypes (Keggin,
Wells–Dawson or Lindqvist). The applied POM complexes exhib-
ited the same cleavage mechanism as the Ce–POM in the previous
study and the activity was observed to be charge dependent, since
A. Bijelic, A. Rompel / Coordination Chem
Fig. 6. Structural comparison between a hydrolytically active POM and the well-
known, proteolytically passive Anderson POM [59]. (A) The proteolytic POM
(Me1-K2; Me  = metal, K = Keggin) consists of one hydrolytically active metal (shown
as  a green sphere, Me1) and two Keggin structures (addenda atoms are depicted
as gray polyhedra, oxygen atoms as small red spheres and the incorporated het-
eroatoms as yellow polyhedra, K2), which is likely to dissociate into the monomeric
1:1 species (Me1-K1) at pH 7.4 and 37 ◦C (for the [Ce(-PW11O39)2]10−) or 60 ◦C (for
the Zr(IV)–POM complexes), respectively. Red arrows indicate the accessibility of
the active metal, which is increased after dissociation. (B) The incorporated metal
atom (depicted as a green polyhedron) is shielded by the POM scaffold (addenda
atoms are illustrated as gray polyhedra and oxygen atoms as small red spheres)
which is indicated by blue circles around the POM. The Anderson POM is rotated
around 90◦ to show it from another perspective (side view) which clearly shows the
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fnaccessibility of the metal. Note that the incorporated heteroatom (yellow polyhe-
ron) of the Keggin structure in (A) is also shielded, so that no direct interaction of
his atom with proteins is observed.
he complexes with the highest POM charge exhibited the highest
ctivity (in the same order of magnitude as the Ce(IV)–POM) [56].
POM-complexes consisting of more than one metal exhibiting
ewis acidity or more than one POM (e.g. Zr(IV)2–POM2) are prone
o dissociate in solution, especially under acidic conditions, into
onomeric complexes (Zr(IV)1–POM1) leading to a structure with
n accessible hydrolytic metal containing free coordination sites
Fig. 6A) [56–58]. Thus, all POMs exhibiting hydrolytic activity have
ccessible metals which are not incorporated and fully enclosed
y the POM enabling them to interact unhindered with the pro-
ein at its amide bonds. Metals incorporated in the POM structure
uch as in the disk-shaped Anderson archetype are shielded by the
OM portion (Fig. 6B) and are thus not able to directly interact
ith proteins [59]. Hydrolysis experiments with POMs lacking a
eteroatom at all or containing a heteroatom metal without Lewis
cidity resulted in no peptide cleavage [54,55]. Thus, the presence
f an accessible and strong Lewis acid metal is essential for its
ydrolytic activity.
. Versatile use of POMs in protein crystallography
.1. POMs as phasing tool
One of the most frequent usages of POMs in crystallography is
heir use in the phasing of macromolecular crystals to overcome the
hase problem. For the MIR  method, heavy atom derivatives, which
eep the protein’s conformation isomorphous, and crystals of the
ative protein are needed. Differences in the scattering behav-
or and thus structure factor amplitudes between the heavy atom
erivative and the native protein crystal are used to determine the
eavy atom positions on a Patterson difference map, which in turn
re used to estimate protein phases [1]. The MAD  technique exploits
he scattering changes caused by anomalous scatterers when the
-ray wavelength is varied around their absorption edge. Similar to
IR, the protein phases are calculated from the induced differences
n their scattering properties (dispersion differences) without the
eed of additional native reﬂection data but requiring data at dif-
erent wavelengths [2]. POMs can be used to obtain heavy atomistry Reviews 299 (2015) 22–38 27
derivatives for MIR-phasing or to act as anomalous scatterers for
MAD-phasing by soaking them into the protein crystals or by co-
crystallization.
The incorporation of POMs is a particularly good choice for
phasing since their numerous connected metal atoms provide a
large number of (anomalous) scattering electrons leading to sig-
nals that are not lost in the noise which is often the case for
single heavy atoms. Even if the individual metal positions are not
resolved, because of the lack of high resolution data or the lack of
internal symmetry within the POM, the POM cluster can act as a
“superatom” which provides useful phases even at low resolution
representing often an advantage in comparison to incorporated
single heavy atoms like Hg2+, Au3+ or Pt2+/4+ [60,61]. Well known
structures like the Wells–Dawson type K6[P2W18O62], Keggin-type
(H5O2)3[PW12O40], Preyssler type H14[NaP5W30O110] and several
tungstophosphates were used to obtain heavy atom derivatives in
the early days [28,32,62,63].
The most prominent usage of POMs was during the structure
elucidation of the ribosome. High resolution structures (up to 3.3 A˚)
were obtained by post crystallization treatment of the 30S subunit
from Thermus thermophilus (850 kDa) with heteropolytungstates,
where K6[P2W18O62]·14H2O (called W18  by the authors) was the
most efﬁcient one, providing a strong anomalous signal indispens-
able for phasing [11]. However, the best resolution (3 A˚) for the
30S subunit structure was obtained without the use of any POM
[64]. Contrary to the aforementioned advantage of POMs over single
heavy atoms, some of them like osmium hexammine [Os(NH3)6]3+
provided the bulk of the phasing information in the case of the 30S
and 50S ribosomal subunit [64–66]. Thus, at least for the ribosomal
structure single heavy atoms have been more successful in phasing
than POMs. However, many single heavy atoms have to be bound
to the protein to exhibit sufﬁcient phasing power and their local-
ization in large unit cells can be very difﬁcult, especially at low
resolution. Therefore, we  suggest that POMs as phasing tools are
still more advantageous than single heavy metals.
The large ribosomal 50S subunit from Haloarcula marismortui
was also treated with the polyoxotungstates, [PW11O39]7− (W11),
[PW12O40]3− (W12) and [P2W18O62]6− (W18), but with little suc-
cess and they did not increase the resolution [67]. However, the
strong signals of the W11  clusters and the resulting difference
Patterson map  of the W11-derivates enabled the display of the
polypeptide exit channel, which is used by elongating polypeptides
to leave the complex, at a time when the resolution of the structure
was still low. Four W11  clusters are bound to this channel marking
its path through the whole ribosomal subunit (Fig. 7).
High resolution structures of riboﬂavin synthase (icosahedral
capsid formed by 60 -subunits, 972 kDa) from Bacillus subtilis
(3.3 A˚), fumarase C (50 kDa) from Escherichia coli (2.6 A˚) and the
proteasome (673 kDa) from Thermoplasma acidophilum (3.4 A˚) were
solved via phases provided by the above mentioned tungsten clus-
ters [68–70].
3.2. POMs promoting protein crystallization
The success of crystallization depends on intermolecular con-
tacts which do not only depend on intrinsic protein properties, but
can also be strongly inﬂuenced by auxiliaries in order to make pro-
teins more amenable to crystallization [4]. In the following, POMs
that have beneﬁcial effects on protein crystallization are discussed
in detail.
3.2.1. POMs stabilizing enzyme conformations
It is known that in many cases protein–ligand complexes are
more likely to crystallize than the apo-form since ligand-binding
results in a more rigid and compact protein structure [71]. Most
importantly the enzyme–ligand complex can be crystallized in
28 A. Bijelic, A. Rompel / Coordination Chemistry Reviews 299 (2015) 22–38
F  surface representation (green). (B) 50S subunit is depicted in surface representation with
3  serving as a point of orientation. The large subunit is rotated by 90◦ around the vertical
a rking the approximate path of the polypeptide exit channel through the entire subunit.
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aig. 7. Large 50S subunit and its exit tunnel. (A) Structure of the large 50S subunit in
0%  transparency and its L2 protein is shown as blue surface without transparency
xis  from the left view. [PW11O39]7− (W11) are shown as clusters of red spheres ma
rucial transition states providing insights about the reaction or
onversion mechanism. The inorganic salts of the transition metals
Mo, V and W),  which are incorporated in POMs as addenda atoms,
ave often been used as inhibitors or as substrate mimics in enzyme
rystallization trials, with the intact and assembled POM being
arely used however. Vanadate is very commonly used in this
apacity, as it is known to inhibit most phosphatases due to its
hemical similarity with phosphate [72,73]. Vanadate (but also
olybdate) is able to form pentacoordinated complexes resulting
n trigonal bipyramidal geometry which is a very good approxima-
ion for the transition state of phosphoryl transfer reactions [74].
owever, the aqueous chemistry of molybdates, tungstates and
anadates is very complex, thus tending to oligomerize to their
olyoxo species (POMs) under conditions with neutral to acidic pH
26,75]. Therefore, upon self-assembly POMs were often identiﬁed
o bind the enzyme close to its catalytic center stabilizing its con-
ormation and thus promoting the crystallization of substrate or
nhibitor bound enzymes [76–81]. POMs can also act as competitive
nd non-competitive inhibitors and thus induce speciﬁc transition
tates by themselves [82]. Crystal structures of enzymes which are
nhibited by POMs rarely show the POM within the active site, but
evealed that the POM does not necessarily intrude into the cat-
lytic center. The enzymes are then inhibited by POM binding to
atalytic important regions such as loops carrying crucial residues
or the enzyme reaction or by POM induced conformations where
he substrate is not able to bind to the active site.
Several examples of inhibiting POMs are deposited in the
DB (see Table 1), one of them is the crystal structure of NTP-
ase1 from Legionella pneumophilia inhibited by a dodecatungstate
[W12O40H2]6−) [53]. The enzyme is trapped in a certain transition
tate not only due to strong electrostatic interactions with the POM,
ut also as a result of the POM’s large size and speciﬁc shape, lead-
ng to the blockage of further molecular motion of the catalytic
left and thus to the inhibitory effect. This “transition state trapp-
ng” was a special beneﬁt for the authors, since it provided more
nsights about the domain motions during the catalytic reaction.
The size- and shape dependency of the inhibitory action of POMs
as also demonstrated by inhibition tests of protein kinase CK2
ith several POMs indicating that with increasing size and charge,
he POM inhibition was enhanced [83]. Small POMs exhibited weak
r no inhibition because the space in the catalytic center is possibly
arge enough to bind a substrate even in the presence of a small
OM.
.2.2. POMs rigidify ﬂexible protein regions
POMs are able to rigidify ﬂexible protein regions as con-
incingly demonstrated for the 30S ribosomal subunit, where
6[P2W18O62]·14H2O (W18), besides providing phasing power,
ppeared to be very beneﬁcial in rigidifying and stabilizing this veryFig. 8. Structure of the small 30S ribosome in surface representation. Protein por-
tions are shown as green and rRNA portions as cyan surfaces. [P2W18O62]6− (W18)
molecules are shown as red spheres based on PDB entry 1I94.
ﬂexible subunit leading to an increase in resolution [11]. Structure
stabilization by soaking the crystal in a W18  containing solution
was in most cases the perquisite for high resolution structures
in the Yonath group, but it should be noted that POM treatment
of 30S crystals (same organism) of the Ramakrishnan group led
to a decrease in crystal quality and they obtained their highest
resolution structures without the use of any POM [11,64]. The con-
formational stabilization was achieved by blocking the movement
of highly ﬂexible protein regions via the non-covalent crosslinking
of symmetry related particles which are positioned along a crys-
tallographic twofold axis. The 30S structure consists of a head, a
platform and a base (see Fig. 8) with the head being very ﬂexible
for functional reasons making its crystallization challenging. W18
clusters were demonstrated to induce a beneﬁcial conformational
change, where the POMs structuralized/froze the entire vicinity of
particle regions, which are crucial for the head motion and there-
fore trapped the structure in this one conformation [12,11]. The
POM bound conformation is similar to the 30S subunit conforma-
tion in a functionally active ribosome structure [84].
3.2.3. POMs enhancing crystal stability and packing
POMs are able to crosslink different monomers in order to
mediate crystal packing [14,15,53,77,85]. These crosslinks are the
result of electrostatic interactions and hydrogen bonds between
POMs and single monomers or domains, respectively. Binding of
negatively charged POM anions to the positively charged surface
patches of at least two protein monomers leads to new crystal
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ontacts by linking these otherwise repulsive surfaces. Besides
ediating or creating new crystal contacts, POMs also bind and
tabilize known protein–protein crystal contacts of several proteins
11,76,81]. The ability to “glue” protein layers, where otherwise no
irect protein–protein interactions could be formed, makes POMs
dditionally attractive for protein crystallization.
Crosslinking ability depends on several factors like total nega-
ive charge, charge distribution, size, shape and symmetry of the
OM. The more negatively charged the POM is the higher the
fﬁnity toward (positively charged) protein regions. Symmetry can
electively direct the POM’s binding site in cases where the internal
ymmetry of the POM correlates with the symmetry of the macro-
olecule. As early as 1987 Ladenstein et al. [86] demonstrated that
 trigonal tungsten cluster [(W3O2(O2CCH3)6]2+ with D3 symmetry
nd the pentagonal heteropolytungstate [NaP5W30O110]14− with
5 symmetry bind at the threefold and ﬁvefold-axis of riboﬂavin
ynthase, respectively. If the POM lacks internal symmetry its mode
f binding and location in the protein structure are random. It seems
owever, that the degree of crosslinking depends on the symme-
ry as well, because if the POM is situated on an X-fold axis, it is
urrounded by X symmetry related protein monomers or protein
ubunits (Fig. 9). These monomers/subunits can then be crosslinked
y the POM (given that no sterical hindrance occurs and that the
harges match for crosslinking).
Apart from the interactions between POMs and proteins, size
nd shape of the POM in some cases plays a tremendous role. If
 POM has the “appropriate” size, it can act as a form of “sticky
pacer” between two repulsive protein monomer surfaces, con-
ecting them at a certain distance, so that these linked monomers
o not clash or sterically hinder each other while being crosslinked
ith one another. This could lead to a reduction in long-range repul-
ion forces between the monomers and at the same time to an
ncrease of short-range attraction which in turn facilitates crys-
allization [15]. According to this model, the shape of the POM
ould be an essential factor for binding. Shape complementarity
etween POMs and protein surfaces could establish closer contacts
etween crosslinked monomers leading to a more favorable and
ense crystal packing (Fig. 10).
. POM–protein structures in the PDB
The PDB was searched for protein structures including POMs in
rder to investigate their interactions and possible impact on the
rotein structure which might have inﬂuenced the crystallization
rocess. Therefore, the ligand search engine from the PDB was uti-
ized and we searched for commonly used transition metals that
ere reported to act as addenda atoms in POMs (Mo, Nb, Ta, V
nd W).  The search yielded 30 PDB entries including 15 different
OMs (as of November 2014) which are summarized in Table 1 giv-
ng information how the POM was introduced into the structure,
he purpose of the POMs used and its impact on protein crystal-
ization and structure elucidation. These 15 POMs are modeled in
he protein structure and assigned a ligand ID making it easy to
nd and to investigate their structures. Unfortunately, there are
lso PDB structures containing unassigned POMs represented as
on-linked single transition metal atoms or oxoanions. Therefore,
e quickly looked through all entries containing Mo6+ (17 entries)
r Mo in general (31 entries), WO42− (47 entries) and VO43− (76
ntries), however, some POMs could be simply overlooked (not
nly by us but also by the respective authors). We  found three
DB entries with unassigned and non-modeled POMs which are
ummarized in Table 2. These POMs were identiﬁed by the fact
hat several transition metal atoms or their oxoanions were found
lustered, exhibiting suitable geometry for a POM and metal–metal
istances of 3.0–3.3 A˚ which is in accordance with values fromistry Reviews 299 (2015) 22–38 29
known POM archetypes [87]. In addition, there are structures which
were solved by using POMs but only the coordinates of the native
crystal are deposited in the PDB, e.g. the crystal structure of the
copper-containing amine oxidase from Pisum sativum (PDB entry:
1KSI) [88] and of the dynein motor domain from Saccharomyces
cerevisiae (PDB entry: 3QMZ) [89]. Both structures were solved
by using [PW12O40]3− derivatives for phasing reasons leading to
enhanced resolutions. However, depositing only the native crystal
coordinates makes the POM contribution in these structures “invis-
ible” for the PDB search engine and are involuntarily omitted in this
review.
Interestingly, in most of the studies that delivered POM–protein
structures, the presence of POMs was rather a coincidence and
appeared often to be beyond the authors’ scope of interest. As
a result the POMs as well as their function and protein binding
ability are scarcely discussed. An example demonstrating unin-
tended POM formation was  the crystallization of the CO-releasing
therapeutic ALF186 with hen egg white lysozyme where the molyb-
denum containing ALF186 after CO release decomposed into a
Keggin type POM [90]. Besides the presence of POMs as inciden-
tal “byproducts” or as enzyme ligands (substrate or inhibitor),
there are also studies where the POMs were used in a targeted
manner, for example, for macromolecular phasing or as a crystal-
lization additive to induce crystallization [10,11,13–15,76,91,92].
There are presently commercially available “Phasing Kits” from Jena
Bioscience with “kits” including phosphotungstate [PW12O40]3−,
metatungstate [H2W12O40]6− and paratungstate [H2W12O42]10−
[93].
4.1. POM structures identiﬁed in the PDB
Most of the 15 POMs found in the PDB are well-known and
described archetypes present in the literature. Among them,
the Keggin-type ([PW12O40]3−, [PMo12O40]3−, [W12O40H2]6−),
Wells–Dawson-type ([P2W18O62]6−), Anderson-type
([TeW6O24]6−), decavanadate ([V10O28]6−), cyclotetravanadate
([V4O12]4−), octamolybdate ([Mo8O28]8−) and heptamolybdate
([Mo7O24]6−). The appearance of these POM structures was mostly
the result of crystallization in solutions containing addenda oxoan-
ions (MoO42−, VO43− or WO42−) under conditions promoting the
spontaneous self-assembly of common POM species or their
addition on purpose [24,102–105]. However, several PDB  entries
contain POMs with sum formulas so far only seen as part of protein
structures like [Mo6O27Hn]n−18, [Mo8O26O(Glu)N(His)Hn]n−5,
[W3O10HnN3](6−n)− and [Mo3O14]10−. Other uncommon POMs in
the PDB are degradation products of larger POM species like the
[Mo3O13]8− anion representing a building block of the Keggin POM
and the [V7O19]3− anion, an incomplete metavanadate cluster.
The analysis of the occupancies (measure of the fraction of
molecules present at the site speciﬁed in the model) revealed
that most of the POMs exhibit high values (24 of 35 investigated
POMs with occupancies >0.65) and thus are not only ordered in
the respective structures but also strongly bound to the protein
[50,51,53,76,77,79,80,85,96,98]. Fractional POM  occupancies are
observed in cases where several POM species are overlapping, one
example is the structure of the MoSto protein where up to 100
molybdenum or tungsten atoms are stored in the inside of the
protein leading to the formation and successive degradation of dif-
ferent POM species (e.g. formation of an octamolybdate Mo8 which
then decompose into Mo7 or Mo5–6 species or the formation of the
large Mo13 species consisting of 13 smaller MoOx blocks). Due to
this formation-degradation equilibria several POM sites are over-
lapped [50–52]. Other reasons for fractional occupancies could be
a low afﬁnity between POM and the protein, POM exhibiting multi-
ple conformations or orientations (due to different binding modes)
or low POM concentration leading to unsaturated binding. Some
30
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Table 1
PDB entries including POMs modeled by the authors.
PDB entry Protein name (organism) POM sum formula ID Origin of POM Purpose of POM use POM impact on
crystallization/structure
Ref.
1L7V ABC transporter (E. coli)  [V4O12]4− V4O Self-assembly in the presence of
VO43− (inhibitor)
Heavy atom derivative
for phasing
Providing initial phases [94]
2D1G Acid Phosphatase A (F.
tularensis)
[V10O28]6− DVT Self-assembly in the presence of
Na3VO4 (inhibitor)
None Structure stabilization (POM
rigidiﬁes a ﬂexible His6-tag)
[81]
1UZI C3 exoenzyme (C.
botulinum)
[V4O12]4− V4O Self-assembly in the presence of
Na3VO4
None Involvement in crystal packing [85]
1E59 Cofactor-dependent
phosphoglycerate mutase
(E. coli)
[V4O13]6− VO3 Self-assembly in the presence of
NaVO3 (inhibitor)
NaVO3 as mutase
inhibitor
Inhibition, stabilization of the
inactive form
[95]
3GQI Human activated receptor
tyrosine kinase
[V10O28]6− DVT Self-assembly in the presence of
Na3VO4 (inhibitor)
None Structure stabilization [80]
1DKT Human cell cycle protein
CksHs1
[V7O19]3− V7O Self-assembly in the presence of
VO3− (phosphate analog)
Substrate analog Binding to active site, stabilization
of the protein’s dimer
[96]
2HHL Human CTD small
phosphatase-like protein
[PW12O40]3− KEG Not described in reference Not described Possible involvement in crystal
packing
[78]
1N7D Human extracellular
domain of the LDL-receptor
[PW12O40]3− KEG Soaking in Na3[PW12O40] Anomalous scatterer
for phasing
Crystal quality improvement by
stabilization of domain packing,
providing initial phases
[76]
4OUA Latent and active
mushroom tyrosinase
PPO4 (A. bisporus)
[TeW6O24]6− TEW Co-crystallization with
Na6[TeW6O24]
Crystallization additive Involvement in crystal packing (no
crystal without POM)
[14]
4PHI Lysozyme (G. gallus) [TeW6O24]6− TEW Co-crystallization with
Na6[TeW6O24]
Crystallization additive Involvement in crystal packing,
induction of new crystal form
[15]
4B1A Lysozyme (G. gallus) [PMo12O40]3− K3G Byproduct of pro-drug
decomposition
None Structure stabilization [90]
4F6T Molybdenum storage
protein (A. vinelandii)
[Mo6O26]16− 6M0  Protein induced assembly in the
presence of Na2MoO4
Analysis of the
assembled POMs
POMs are formed and stabilized by
the protein matrix
[51]
4F6T Molybdenum storage
protein (A. vinelandii)
[Mo8O28]8− 8M0  Protein induced assembly in the
presence of Na2MoO4
Analysis of the
assembled POMs
POMs are formed and stabilized by
the protein matrix
[51]
2OGX Molybdenum storage
protein (A. vinelandii)
[W3O13]8− WO3  Protein induced assembly in the
presence of WO42−
Analysis of the
assembled POMs
POMs are formed and stabilized by
the protein matrix
[50]
4NDOa Molybdenum storage
protein (A. vinelandii)
[Mo3O13]8− M10 Protein induced assembly in the
presence of Na2MoO4
Analysis of the
assembled POMs
POMs are formed and stabilized by
the protein matrix
[52]
4NDOa Molybdenum storage
protein (A. vinelandii)
[Mo8O28]8− 8M0  Protein induced assembly in the
presence of Na2MoO4
Analysis of the
assembled POMs
POMs are formed and stabilized by
the protein matrix
[52]
4BVO NTPDase1 (L. pneumophila) [W12O40H2]6− E43 Co-crystallization with
Na6[W12O40H2]
As inhibitor Induction of new crystal form
(partially opened active site)
[53]
4BVP NTPDase1 (L. pneumophila) [Mo8O28]8− 8M0  Soaking in (NH4)6[Mo7O24] Hydrolase inhibitor Involvement in crystal packing
(rigidifying a ﬂexible His6-tag)
[53]
4BVP NTPDase1 (L. pneumophila) [Mo7O24]6− MO7 Soaking in (NH4)6[Mo7O24] Hydrolase inhibitor Rigidifying ﬂexible protein regions [53]
4BVP NTPDase1 (L. pneumophila) [Mo3O14]10− 6LL Degradation product of
(NH4)6[Mo7O24]
Hydrolase inhibitor Rigidifying ﬂexible protein regions [53]
4BRH NTPDase1 (L. pneumophila) [V10O28]6− DVT Self-assembly in the presence of
VO43− (phosphate mimic)
None No special impact [79]
3ZX0 NTPDase1 (R. norvegicus) [Mo7O24]6− MO7 Soaking in (NH4)6[Mo7O24] Hydrolase inhibitor Inhibition and conformation
stabilization
[97]
3ZX2 NTPDase1 (R. norvegicus) [V10O28]6− DVT Self-assembly upon soaking in
Na3VO4
Hydrolase inhibitor Inhibition and conformation
stabilization
[97]
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POMs lying on crystallographic symmetry axis are also not fully
occupied, e.g. a POM on a two-fold axis is set to 50% occupancy
since one half of the POM is provided by two  oppositely positioned
asymmetric units [14,76].
4.2. POM interaction and position within the protein structure
The strength of POM–protein binding depends, inter alia, on
the number of interacting residues, the kind of interactions, the
symmetry and interaction distance. Everything was observed from
POMs located at the periphery of the structure with POM–protein
distances over 5 A˚ to covalently bound POMs. However, distances
ranging from 2.6 to 4.0 A˚ were predominant in the structures indi-
cating that the strength of POM–protein interactions range from
strong over moderate to weak interaction [106]. It is not sur-
prising that almost all POMs are located at positively charged
protein regions due to their negative charge and the ability to form
charge–charge interactions and hydrogen bonds as discussed in
Sections 2.1 and 2.2. This situation is also reﬂected in Fig. 11 where
all amino acids are summarized which have been determined to be
involved in POM-binding in the 30 PDB entries. Besides the basic
residues of which at least one was present in every POM  binding
site, polar but uncharged side chains are also involved in POM-
binding, whereas unpolar and negatively charged residues play a
minor role. The relatively high content of polar residues indicates a
high contribution of hydrogen bonds in POM-binding since almost
all polar uncharged side chains have one hydrogen donor atom.
By looking at the secondary structure elements, which harbor
the interacting amino acids, the potential of POMs to bind to ﬂex-
ible protein regions has been demonstrated (Fig. 12). However,
the determination of ﬂexible protein parts was not that simple
when not described by the authors. One possibility is to look at
the B-factor, which is a reﬁnement parameter during structure elu-
cidation (giving the uncertainty about the position of atoms due
to thermal vibrations and static disorder), but this factor depends
highly on the data resolution and structural environment (e.g.
POMs can drastically inﬂuence this value) [109]. Flexibility itself
depends on various factors and thus, we often had to simplify the
terms “ﬂexible” and “rigid” without considering factors like the suc-
cession of secondary structures (motifs) and interactions (H-bonds)
between single motifs and domains. Loops and loop-like structures
(turns, bends, etc.) lacking tertiary structure with relatively high
B-factors and consisting of solvent interacting residues (polar and
charged) were referred to as “ﬂexible” regions whereas -helices
and -strands (part of -sheets) as “rigid” protein regions. Accord-
ing to this we  analyzed the 30 PDB structures summarized in Table 1
and found that about 65% of the secondary structure elements har-
boring amino acids, which are involved in POM-binding, are of
“ﬂexible” nature (Fig. 12). This conﬁrms the assumption that POMs
bind to moveable and solvent accessible protein parts, which is
essential for their reported ability to rigidify proteins and to create
new crystal contacts which are often located at protein surfaces.
Besides loops and long turns, so called “hinge regions” consisting
of a loop and the termini of either -helices or -strands (which
are connected by this loop) were preferentially bound and catego-
rized by us as “ﬂexible” protein regions. These hinge regions are
often found in active sites of enzymes, responsible for the opening
and closing of the reaction cleft, where rigid and blocking sec-
ondary structures have to be removed to bind a substrate [110].
Thus, POMs bound to these sites were mostly used as inhibitors to
block the motion of large and rigid motifs. Note that the statistics
in Figs. 11 and 12 were created according to our observations and
therefore the presented data are only showing a trend.
Another factor inﬂuencing the position and binding of POMs to
proteins is symmetry, as already indicated in Section 3.2.3. One
good example deposited in the PDB where the internal symmetry
32 A. Bijelic, A. Rompel / Coordination Chemistry Reviews 299 (2015) 22–38
Table 2
PDB entries containing POMs which are not modeled in the protein structure.
PDB entry Protein (organism) Number of metal atoms Origin of POM Purpose of POM use POM impact on
crystallization/structure
Ref.
4PE5 NMDA receptor ion
channel (R. norvegicus)
12 W probably
[H2W12O40]6−
Soaking in Na6[H2W12O40] Heavy atom derivative
for phasing.
Improvement of crystal
quality
[99]
3FYH DNA repair and
recombination protein
RadA (M.  voltae)
12 W probably
[H2W12O40]6−
Added as Na6[H2W12O40] Rad inhibitor Stabilization of the inactive
form
[100]
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c2G8H RNase H (B. halodurans) 6 V maybe Lindqvist
[V6O19]8−
Self-asse
presence
f the protein directed the POM’s position is the binding of two
V7O19]3− anions which are sitting along the threefold-axis of Uri-
ine Phosphorylase from E. coli (PDB entry: 1RXS [98]. The structure
f this protein can be described as an assembly of three homodi-
ers forming a homohexamer. Each [V7O19]3− is involved in six
lectrostatic (charge–charge) interactions by binding two  residues
rom three homodimers, which is illustrated in Fig. 13.
.3. Heterogeneous crystal formation enabled by POMs
One POM was also found to mediate a “heterogeneous crys-
al formation”. Mushroom tyrosinase PPO4 was crystallized in the
resence of the Anderson–Evans type POM Na6[TeW6O24]·22H2O
TEW) and resulted in a heterogeneous structure containing both
he latent and active form (lacking a 21 kDa C-terminal domain)
f this protein [13,14]. The fact, that two differently truncated
roteins were co-crystallized in the same structure in a 1:1 ratio
as astonishing since crystallization is usually seeking for homo-
eneity. Each heterodimer (latent and active form) is on the one
ide connected to its symmetry mate via a protein–protein con-
act and on the other side linked to the next heterodimer by two
nderson–POMs (Fig. 14) resulting in a 1:1:1 stoichiometry (latent
orm PPO4:active form PPO4:TEW). This pattern is repeated
hroughout the crystal. Structural analysis revealed that the
bsence of TEW, which is located on a twofold axis, would not have
esulted in the heterodimer being packed together due to sterical
easons and repulsive interactions between the monomers. This
ind of crystal packing is very special and demonstrates the possi-
ility to crystallize two protein forms within one single crystal.
. POMs as crystallization additives
.1. Prerequisites and considerations when applying POM in
acromolecular crystallization
Diverse POMs are able to have a remarkable inﬂuence on pro-
ein crystallization making them potential additives. Care should
e taken however, to ensure the correct choice of the appropriate
OM for crystallization, because of their high variability in geom-
try and other properties they often present “surprise packages”
n aqueous solutions, thus entailing disadvantages for proteins and
heir crystallization.
First of all the administered POM should be able to interact
ightly with proteins and must be highly soluble in aqueous buffers
n order to be applied in sufﬁciently high concentrations during the
rystallization trial. POMs as polyanions in general possess a high
olubility in various solvents and therefore their water solubility
an be increased by simply altering their counter cation (e.g.
ations like H+, Na+, K+ or Li+) making POMs more soluble in aque-
us solutions [111]. Since POMs are negatively charged the target
rotein should harbor positively charged portions, which can
e bound electrostatically. In addition, the total negative charge
hould be high enough for the binding itself as with decreasing
harge of the POM the interaction strength is also decreased [48].in the
VO3
VO3− as substrate
mimic
Stabilization of an
intermediate conformation
[101]
The right combination of addenda and heteroatom can provide
very high negative charges.
The size of the POM should also be considered, because only
appropriately sized POMs are able to reach also not exposed pos-
itively charged protein patches or catalytic centers of enzymes.
Therefore, too large POMs should be avoided, but also because
charge distribution over a vast surface could lead to a “charge
dilution” which may  in turn result in insufﬁcient attractive forces
being too weak to stabilize crystal contacts. The largest POM
successfully applied so far in X-ray crystallography according
to the PDB (Table 1) is the [P2W18O62]6− POM exhibiting the
dimensions 10.5 × 12 × 9 A˚, whereas the smallest deposited POM
is [Mo3O14]10− exhibiting the dimensions 6 × 5.5 × 3 A˚. Besides the
size, the shape was also a crucial factor since it is occasionally
favorable for the POM enabling it to intrude into uniquely
formed cavities or catalytic centers, especially for trapping cer-
tain enzyme conformations (by occupying the substrate binding
site or mimicking speciﬁc geometries) or crosslinking bigger
domains.
Another important prerequisite is the hydrolytic stability of
POMs in aqueous media. Many POMs, such as the Wells–Dawson
type [P2Mo18O62]6−, can decompose to smaller polyoxoanions or
undergo multiple condensation-hydrolysis equilibria depending on
pH and temperature [112]. However, most of the well-known POMs
are generally stable at acidic pH and decompose under basic con-
ditions [26]. The typical pH range in protein crystallography is
2–10, thus it would be ideal if the POM could largely cover this
range. Unfortunately, it is rather challenging to accurately deter-
mine the exact POM species in solution, so it is not possible to
quickly check the predominant species under experimental condi-
tion. Several spectroscopic techniques, like UV/Vis or NMR  (e.g. 31P
NMR  for phosphate containing Keggin POMs, 51V NMR and 183W
NMR to monitor vanadium- and tungsten-based POM species),
can be performed to roughly check the POM integrity [113,114].
Electrospray-ionization mass spectrometry (ESI-MS) was also use-
ful for this purpose, but high-resolution (soft-ionization) MS-ESI
equipment is needed to resolve complex isotropic distribution
patterns of transition metals [115]. Thus, appropriate conditions
should be chosen to keep the POM species intact which requires
extensive characterization of the synthesized POM prior to its appli-
cation in protein crystallography.
Apart from ensuring the stability of the POM, the structure
of the protein should also not be disturbed. Incorporation of
POMs into the protein system has to be isomorphous and thus
not denaturating or hydrolytically cleaving it. In Section 2.5, we
discussed POM-types such as the [Ce(-PW11O39)2]10− and dif-
ferent Zr(IV)–POM complexes that are able to selectively cleave
proteins, therefore POMs with an easily accessible strong Lewis
acid metal should be avoided to save the integrity of the pro-
tein (Fig. 4). However, some commonly used POMs not containing
strong Lewis acids, like Preyssler’s anion [NaP5W30O110]14−, induce
partial denaturation which was  detected by circular dichroism
(CD) spectroscopy and thermal denaturation experiments [42]. The
POM should therefore be tested for undesired effects by incubation
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Fig. 9. Symmetry inﬂuencing the degree of POM crosslinking. (A) An
Anderson–Evans type POM ([TeW6O24]6−) is located on a crystallographic
threefold axis and thus interacts with three protein monomers. The POM is
shown in polyhedra representation (color code: tellurium atom = brown, tungsten
atoms = cyan). The proteins are depicted as green cartoons (hen egg white lysozyme
is  used as an example). (B) The Preyssler type POM ([NaP5W30O110]14−) with a
pentagonal symmetry is sitting on a crystallographic ﬁvefold axis and is thus
able to interact with ﬁve symmetry related protein monomers. The POM is
s
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w
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Fig. 10. Schematic overview of the beneﬁcial effects of POM sizes and shapes.
On  the left of the ﬁgure there are two protein portions shown (green half cir-
cles) with a positively charged surface (shown in blue) staying very close to each
other and thus leading to sterical clashes (red crosses) and electrostatic repul-
sion (red bar). This situation will never result in crosslinking of the two regions
or  the formation of a crystal contact. However, in the presence of a POM, e.g.
[TeW6O24]6− Anderson type (shown in ball and stick representation, color code:
tellurium atom = brown, tungsten atoms = marine, oxygen atoms = red), the regions
are electrostatically crosslinked by the POM and are at the same time far enough
apart such that no sterical hindrances are expected. The situation on the right of the
ﬁgure has the potential to result in a new crystal contact.
Fig. 11. Overview of how often the 20 amino acids were involved in the
POM–protein binding based on the PDB related structures from Table 1. The ordi-
nate indicates the number and the abscissa the kind of amino acids present in the
interactions. Amino acids are categorized in basic (blue bars), acidic (red bars), polar
but uncharged (dark yellow bars) and unpolar (green bars) ones. In the upper right
of  the ﬁgure the division into the four categories is displayed as a pie chart with the
same coloring as the bar graph. All 30 structures from Table 1 were analyzed with
the molecular visualization system PyMOL [107] and the model building and vali-
dation system Coot [108] with respect to POM–protein interactions. POM–protein
interactions with interaction distances up to 4.5 A˚ were taken into account. Over-hown in polyhedra representation (color code: sodium atom = brown, tungsten
toms = cyan). The proteins are depicted as green cartoons (hen egg white lysozyme
s  used as example).
ith the protein and subsequent SDS-PAGE or CD analysis prior to
rystallization.
The choice of the appropriate buffer is also an important point
n protein crystallization experiments with POMs. The components
f the buffer should not interfere chemically with the POM and
hus change its structure as was shown in TRIS-buffered solu-
ions where small amounts of POM were converted into POM–TRIS
omplexes [116]. Buffers containing volatile compounds tend toall,  241 residues are involved in these interactions and subsequently categorized as
shown above.
change the pH of the solution over time and should therefore be
avoided since the stability of the POM is pH-dependent. Further-
more, the concentration of the buffer could also have negative
effects on crystallization, especially in the case of salt contain-
ing buffers when increasing the concentration is coupled with an
increase in ionic strength. This results in a decrease of binding
afﬁnity between POM and the protein since salt components could
compete for binding of charged residues. A further threat related
with increasing buffer concentration is related to the reported
increase in POM degradation constants, which was suggested to be
the result of the enhanced ability of the POM to exchange protons
with the solvent and thus to become more susceptible to hydrolysis
[104].
5.2. Advantages of POMs over common crystallization agentsMany aspects make POMs ideal candidates for crystallization
additives and are shared by other commonly used additives like
small molecules or ions. However, POMs have some advantages
34 A. Bijelic, A. Rompel / Coordination Chem
Fig. 12. Overview of the involvement of secondary structure elements in POM-
binding based on 30 PDB entries. (A) The ordinate shows the number of secondary
structure elements that harbor amino acids that are involved in POM binding. The
abscissa presents which secondary structure elements are involved in the binding
of  POMs. (B) Division of the secondary structure elements from (A) into “ﬂexible”
and “rigid” regions, where loops and loop-like structures (turns, bends, etc.) lacking
tertiary structure with relative high B-factors and consisting of solvent interacting
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oesidues where deﬁned as “ﬂexible” parts and -helices and -strands which are
ot part of hinge regions as “rigid” parts. About 65% of the in POM-binding involved
lements are ﬂexible.
oing for them. They can be used as phasing tools delivering a
igher number of connected heavy atoms or anomalous scatterers
han ordinary single heavy scatterers resulting often in a signif-
cantly enhanced anomalous signal which is useful even at low
esolution by acting as a “superatom” [60]. In addition, only a few
inding sites for POMs are necessary whereas ordinary heavy atoms
ave to bind to many sites to provide useful phases, especially for
arge proteins.
Furthermore, most of the POMs bear very high negative charges
in comparison to small molecules or ions), which are dispersed
ver a large surface, but still strong enough to crosslink more
onomers than most of the commonly used small crystallization
gents leading to an increase in the crystallization probability.
In regard to enzymes, we did indicate in Section 3.2.1 that bulky
OMs do not necessarily have to reach the catalytic center to inhibit
ig. 13. Structure of Uridine Phosphorylase from Escherichia coli. (A) The protein is a homo
he  protein is shown as cartoon, each homodimer colored in a different shade of green. Th
xygen atoms = red) but only 6 VOx units were modeled in the structure, because the autho
B)  Side view of (A) to better demonstrate the presence of the two [V7O19]3− which are lyin
nteraction, where the interacting residues are depicted as ball and stick (color code: carbo
ne  nitrogen from an arginine and one nitrogen from a histidine to the electrostatic interistry Reviews 299 (2015) 22–38
the enzyme or to trap it in a conformation which is possibly more
amenable to crystallization. This trapping can be achieved by ste-
rically constraining the space available for domain motion leading
to a higher structural rigidity.
As discussed in Section 3.2.3, the large size of the POM is also
able to provide a certain distance between the monomers/domains
that are linked via the POM resulting in the reduction of possible
clashes between the connected monomers/domains. In contrast,
crosslinks mediated by small molecules or ions require a close con-
tact between the monomers which could lead to sterical hindrance
and/or insufﬁcient shielding of protein–protein repulsion.
Lastly, we  wish to discuss a property of POMs that is not
necessarily an advantage but could demonstrate that POMs are
able to beneﬁcially affect the phase behavior of the crystalliza-
tion drop and thus promoting crystal formation. Zhang et al.
[117] demonstrated that multivalent cations are able to induce a
so-called re-entrant condensation (RC) including a charge inver-
sion on the surface of acidic proteins (Fig. 15). This means that
the crystallization drop is clear at the beginning of the process
due to the solubility of the protein, but with increasing cation
concentration the negatively charged protein adsorbs more and
more cations until its charge is completely neutralized and the sol-
ubility reaches its lowest point, thus the drop becomes turbid. If the
cation concentration is further increased more cations are attached
on the protein’s surface giving it a positive charge and the precip-
itated protein in the drop re-dissolves gradually. During this RC
process a special phase behavior can be observed where the long-
range repulsion forces (protein in solution) inhibiting aggregation
between protein molecules are overwhelmed by the short-range
attraction forces leading to protein aggregation [118–120]. This
behavior is predominant in a crystallization phase region which
is called the liquid–liquid-phase-separation (LLPS) region occur-
ring in supersaturated protein solutions at very high protein and
precipitant concentrations leading to the formation of additional
drops within the crystallization drop due to the development of
co-existing phases with clearly different protein content [121,122].
The LLPS zones of some proteins (e.g. human serum albumin) were
determined and targeted crystallization at the boarders or within
these LLPS zones led to “controlled” crystallization. This whole
complex procedure and phenomenon could be transferable to neg-
atively charged POMs and positively charged proteins. POMs are
able to inverse the surface charge of positively charged proteins
and to induce liquid–liquid-phase-separation (“drops in drop”), but
more (physical) studies are needed to prove that POMs are able to
induce favorable phase behavior as demonstrated by Zhang et al.
for cations in solutions of acidic proteins [15,59].
hexamer of which structure can be described as the assembly of three homodimers.
e [V7O19]3− anions are shown as ball and stick (color code: vanadium atoms = gray,
rs used the trimeric head of the metavanadate from PDB entry 1DKT as a model [96].
g above each other along the threefold-axis. (C) Illustration of the [V7O19]3−–protein
n atoms = green, nitrogen atoms = blue). Every interacting monomer is contributing
action with each [V7O19]3− molecule.
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Fig. 14. Crystal packing of mushroom tyrosinase PPO4 (polyphenol oxidase 4). In the upper left of the ﬁgure the Anderson POM [TeW6O24]6− (TEW) is depicted from two
perspectives in ball and stick representation (color code: tellurium = brown, tungsten = blue, oxygen = red). On the left the [TeW6O24]6− mediated crosslink of two heterodimers
is  shown with illustration of the [TeW6O24]6−–protein interactions in insets. PPO4 is demonstrated as cartoon with differently colored protein forms and heterodimers (color
code:  active form of heterodimer 1 = dark cyan, latent form of heterodimer 1 = cyan, active form heterodimer 2 = gold, latent form heterodimer 2 = yellow). Interacting side
chains  are shown as ball and stick (color code: carbon = dark cyan/cyan/gold/yellow, nitrogen = blue) and water molecules are depicted as small red spheres. On  the right of the
ﬁgure  the crystal packing in a 1 × 2 × 1 supercell is illustrated. The proteins are shown in differently colored surface representation and the [TeW6O24]6− anions as red spheres.
Every  heterodimer is connected to two other dimers, where the linkage on the one side being mediated by two [TeW6O24]6− and on the other site via a protein–protein
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ynteraction. This motif is repeated throughout the cell demonstrating the role of [Te
.3. The superiority of the Anderson–Evans type POM over other
OMs in protein crystallization
As the charge of POMs in combination with its size and
hape seems to be the predominant factors for protein binding
nd crosslinking, one should focus on POM archetypes which
ave already been applied successfully in protein crystallization
Table 1). One POM type we want to highlight is the highly
oluble Anderson–Evans POM, because it has a very special struc-
ure in comparison to other POM types with a roughly spherical
hape (e.g. Keggin POM with dimensions 10 × 9 × 10 A˚). The disk-
haped Anderson POM with the average dimensions 9 × 7.5 × 3 A˚
s able to position itself into narrow protein clefts or to migrate
hrough narrow channels in order to reach protein parts inac-
essible for other POM types (Fig. 6B). Despite its ﬂat structure
ts high negative charge (e.g. 6− for the tellurium(VI) centered
ne) is distributed over a sufﬁcient large area and depending on
ts orientation it can provide crosslinks between monomers with
onomer-monomer distances ranging from approximately 5–8 to
1–14 A˚. [TeW6O24]6− was successfully applied in crystallization
Table 1) crosslinking monomers in different orientations and thus
roviding close contacts of variable length between them (Fig. 16)
14,15]. Therefore, applying this POM type with a higher charge
than e.g. −6) could enhance the crystallization success of proteins
n combination with this additive. The synthesis of the hydrated
TeW6O24]6− salt is reported in [13], but also the synthesis of a
u(II) substituted [CuW6O24]10− Anderson anion with a negative
harge of −10 was reported but not used in crystallization trials
et [123].4]6− as a form of “glue” between the protein layers.
Furthermore, Na6[TeW6O24] is stable in the range of pH 4–9,
which largely covers the pH range at which protein crystallization
was successfully performed (pH 2–10, but predominantly pH 4–9)
and thus making it widely applicable for protein crystallization.
Further properties encouraging the use of the Anderson POM  for
protein crystallization are its lack of denaturating or proteolytic
effects on several proteins and its suitability for hybridization with
various organic functionalities to synthesize tailor-made POMs tar-
geting special protein sites [59].
5.4. Outlook
POMs are very versatile according to their structure and chemi-
cal properties which can be ﬁne-tuned in favor of the crystallization
of certain proteins. They can be especially helpful for basic proteins
or proteins bearing at least a positively charged portion. How-
ever, some efforts are made and further will follow to address
more groups of proteins. Interestingly, different POMs (particu-
larly differently charged) induce different crystal forms for the
same protein. An example, where unfortunately no suitable crys-
tals for X-ray diffraction experiments were obtained but which still
does demonstrate the POM’s ability to induce crystal growth, is
the formation of rods and 2D crystals of the prion protein (PrP)
[124]. The Keggin type POM, Na2H[PW12O40], with a low negative
charge favored the formation of rods, whereas (NH4)6[H2W12O40]
with a higher negative charge favored the assembly of 2D crystals.
Thus, it was suggested that another POM could be able to induce
the formation of 3D crystals of PrP suitable for X-ray diffraction
experiments. These structures could lead to new information about
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Fig. 15. Phase behavior of a solution containing an acidic protein (e.g. human serum
albumin) in the presence of a multivalent cation (e.g. Y3+). (A) The phase diagram
demonstrates that the reentrant condensation phase behavior consists of three
regimes (regime I, II and II) which are separated by two critical salt concentrations,
c* and c**, where c* indicates the salt concentration at which the protein solution
becomes turbid with increasing salt concentration and c** the salt concentration at
which the solution becomes clear again upon further increase of the salt concen-
tration. Regime II (in between c* and c**) contains a phase separation region, the
so-called liquid–liquid-phase separation region (LLPS). (B) The charge inversion of
the  protein is shown as a function of salt concentration. The charge inversion takes
place within regime II, where the solution is turbid because the surface of the acidic
protein is gradually saturated by the multivalent cations until the surface charge
is  completely neutralized and the protein reaches its lowest solubility (during the
course the LLPS region is traversed if the protein concentration is high enough). Fur-
ther increase of the salt concentration (>c**) leads to the attachment of more cations
giving the protein a positive net charge which increases the solubility of the protein
again and making the protein solution clear again. This ﬁgure is a modiﬁed version
from reference [122], which was kindly provided by Schreiber, Tübingen, Germany.
Fig. 16. [TeW6O24]6− bound to hen egg white lysozyme in two different orienta-
tions. (A) Two lysozyme monomers are crosslinked via the ﬂat site of [TeW6O24]6−
and thus are very close to each other (8.0 A˚). (B) In this case the [TeW6O24]6− lies
horizontally between both monomers leading to a larger distance between them
(14.0 A˚).  This shows that the shape and the orientation of the POM can lead to var-
ious binding modes and thus could induce versatile crystal packing. The protein is
shown as differently colored cartoons to distinguish different monomers. Interacting
side chains are depicted as sticks (color code: carbon atoms = green/cyan, nitrogen
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Fig. 17. Diagram showing the number of X-ray structures of proteins (soluble and
membrane proteins) and solely membrane proteins deposited in the PDB since
1972 (annotation of the abscissa begins at 1974) (as of November 2014). Red dia-
monds represent the number of protein structures, whereas blue triangles indicate
the number of crystallized membrane proteins. Only protein containing structurestoms = blue) with black dashes indicating the interaction with the [TeW6O24] . The
olyoxotungstate is illustrated as ball and stick (color code: tellurium atom = brown,
ungsten atoms = marine, oxygen atoms = red).
iseases like scrapie, Creutzfeldt–Jakob disease or bovine spongi-
orm encephalopathy (BSE).
Hybrid organic–inorganic POMs could be the key for access to
he crystallization of more proteins, since the majority of POM
tructures published these days are hybrid structures [59,125].
he combination of inorganic POMs and organic functionalities
ould be used to synthesize tailor-made POMs that could bind
peciﬁc sites on a certain protein via organic functional groups.
oreover, the attachment of a large hydrophobic moiety on the
OM could be applied to membrane protein crystallization. Most
f the membrane proteins are not soluble in aqueous buffers and
o therefore form amorphous precipitates due to their hydropho-
ic domain which physiologically interacts with membranes. This
ntractability against crystallization makes them the “real bot-
leneck in crystallization” since membrane proteins are clearly
nder-represented in the PDB. Fig. 17 depicts the number of 3D
tructures of proteins against the number of membrane proteins
eposited in the PDB since 1972 which have been solved by X-ray
iffraction experiments (structures resulting from other methods
re excluded). The few membrane protein structures which arewhich have been solved by X-ray diffraction analysis (according to their UniProt
number) where taken into account, so that every protein was included only once in
the  statistic.
available were crystallized by coating the hydrophobic parts with
detergents to overlay them with ionic groups to enhance their solu-
bility [71]. Thus, the suggested hybrid POMs with the hydrophobic
portion could play a similar role as the detergent by binding the
hydrophobic region and decorating it with a high negative charge
resulting in higher solubility, less ﬂexibility and at the same time
providing anomalous signals. This might be a good approach to
obtain membrane protein structures as a long term application for
hybrid POMs.
6. Conclusion
The examples summarized here clearly demonstrate the high
efﬁciency of POMs as a valuable tool in crystallization and crystallo-
graphic studies in general. In some cases POM was indispensable for
crystal growth or at least for new crystal forms. The application of
POMs in the ﬁeld of protein crystallography will hopefully grow in
the future providing crystal structures of proteins whose structure
are unknown to this date like those of membrane proteins. Further
research should include crystallization screens with different POMs
applied to various proteins to gain more insight about the POM
mediated protein–protein contacts which are necessary for crys-
tallization and of course the targeted synthesis of specially tailored
POMs to address more groups or sites within certain proteins. How-
ever, besides synthesizing new POMs or screening different POM
archetypes for protein crystallization, the advantages highlighted
here of the Anderson structure should be taken into consideration
for further investigation in order to ﬁne-tune its application in pro-
tein crystallization. Furthermore, the effect of diverse POMs on the
phase behavior of protein solutions should also be investigated in
more detail. The recent successful applications of POMs  in crystal-
lization suggest that future utilization will bring beneﬁts to several
ﬁelds of chemistry like pharmacology, inorganic chemistry and
especially structural biology which all depend on the input from
3D protein structures.
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